江苏时时彩基本走势图: Genewiz收购Beckman Coulter基因组服务业务
- 互联网2015年12月22日 11:37 点击：1039
Genewiz to Acquire Beckman Coulter's Genomic Services Business
Genomics service provider Genewiz said today that it has agreed to acquire Beckman Coulter's genomic services business.
The deal's financial terms were not disclosed. It has been approved by both boards and will close immediately, Genewiz added.
Beckman Coulter's genomic service business provides sequencing services — including comprehensive Sanger sequencing, next-generation sequencing, bioinformatics, and CLIA and clinical services — to healthcare businesses, academia, and government institutions. Genewiz chairman and CEO Steve Sun praised the deal in a statement today, saying the acquisition "is an ideal fit with Genewiz's global strategy and expansion plans."
Beckman Coulter's genomics services business has proven its leadership role in the market, Sun added, and its experts "have built an efficient workflow that allows for the delivery of quality and timely results to its customers. The integration of these two businesses will allow for an increased level of service and value to customers worldwide."
South Plainfield, NJ – December 21, 2015 – Leading global genomics service provider, GENEWIZ, has signed a definitive agreement to acquire the genomic services business of Beckman Coulter, which delivers expert genomics sequencing solutions to healthcare businesses, as well as academic and government institutions worldwide (GS).
“The genomic services business of Beckman Coulter is an ideal fit with GENEWIZ’s global strategy and expansion plans,” said Dr. Steve Sun, GENEWIZ Chairman and CEO. “Our two companies share a common mission and vision, to offer scientists around the world consistently-reliable genomics service solutions that will advance innovations and scientific discoveries.”
The synergies of this acquisition will support GENEWIZ’s global expansion strategy by leveraging GS’s 25+ years of genomics expertise and capabilities. GS’s comprehensive Sanger Sequencing, Next Generation Sequencing, Bioinformatics, and CLIA/Clinical services will complement GENEWIZ’s existing genomics services. With an international presence in the U.S. and a Pan-European presence centered in the UK, GS presents an immediate opportunity to strengthen GENEWIZ’s global access and value to customers through a stronger network of global labs and office locations in the U.S., UK, China, and Japan.
“GS’s proven leadership and experienced team of industry experts have built an efficient workflow that allows for the delivery of quality and timely results to its customers,” continued Dr. Sun. “The integration of these two businesses will allow for an increased level of service and value to customers worldwide. We look forward to working with the talented GS team to best serve our customers, and be an instrumental part of the future growth of GENEWIZ.”
GS and GENEWIZ will collaboratively align to ensure there is a seamless transition for both organizations and its customer base. The agreement has been approved by the boards of directors of both companies and closed effective immediately.
About the genomic services business of Beckman Coulter
- 凡本网注明“来源：来宝网”的所有作品，版权均属于来宝网，转载请必须注明来宝网， 时时彩网络平台，违反者本网将追究相关法律责任。